Skip to main content
. 2024 May 7;11:1377958. doi: 10.3389/fcvm.2024.1377958

Table 2.

Changes in the hemodynamic and echocardiography parameters in the three study groups.

CTLF (n = 15) CTHF (n = 15) Control (n = 15) ANOVA p
Baseline 12 weeks Baseline 12 weeks Baseline 12 weeks
Resting HR, b/min 67.4 ± 11.6 64.3 ± 17.4* 64.6 ± 13.2 60.0 ± 15.3* 66.1 ± 11.8 67.1 ± 20.5 0.034
Resting SBP, mmHg 126.6 ± 34.0 121.1 ± 44.7* 125.8 ± 27.4 115.6 ± 39.0* 126.1 ± 30.9 125.5 ± 42.1 0.028
Resting DBP, mmHg 82.2 ± 14.7 80.2 ± 16.7 83.6 ± 14.4 82.2 ± 20.4 82.8 ± 15.3 81.3 ± 16.4 0.311
Time at ergometric test, s 345.5 ± 71.8 434.6 ± 88.2* 339.0 ± 96.4 442.9 ± 74.8* 341 ± 93.5 375 ± 86.1 <0.001
Echocardiography
LVEDV, mm3/m2 66.6 ± 22.3 67.8 ± 17.4 67.9 ± 19.5 68.3 ± 24.0 68.7 ± 18.8 68.3 ± 26.3 0.211
LVESV, mm3/m2 36.7 ± 12.3 37.0 ± 14.5 37.1 ± 14.6 36.8 ± 12.7 37.6 ± 13.7 36.8 ± 11.1 0.141
LVEF, % 55.3 ± 8.4 54.6 ± 7.9 54.6 ± 7.2 54.1 ± 8.8 54.3 ± 11.8 54.1 ± 8.4 0.152
LVGLS, % −17.3 ± 4.8 −18.8 ± 5.5 −18.5 ± 4.1 −21.8 ± 6.7*,** −17.7 ± 5.1 −17.9 ± 5.3 0.017
E, cm/s 57.5 ± 14.3 58.3 ± 17.0 58.7 ± 18.9 60.3 ± 11.8 57.8 ± 11.8 59.7 ± 16.3 0.242
A, cm/s 59.0 ± 16.1 60.4 ± 15.1 62.6 ± 16.3 61.8 ± 13.5 61.2 ± 17.4 60.9 ± 15.4 0.286
E/A ratio 0.97 ± 0.3 0.93 ± 0.5 0.94 ± 0.5 0.96 ± 0.4 0.94 ± 0.7 0.93 ± 0.3 0.175
E′, cm/s 6.3 ± 1.3 6.7 ± 2.2 6.7 ± 1.7 7.0 ± 3.1 6.5 ± 2.2 6.9 ± 2.6 0.138
E/E′ ratio 9.1 ± 2.0 8.7 ± 1.8 8.7 ± 1.8 8.6 ± 2.4 8.8 ± 1.8 8.7 ± 3.0 0.187
TRV, m/s 1.8 ± 0.6 1.7 ± 0.6 1.9 ± 1.6 1.7 ± 0.6 1.7 ± 0.9 1.7 ± 1.1 0.295
PALS, % 14.0 ± 4.6 17.2 ± 6.1* 13.8 ± 2.9 19.8 ± 6.4*,** 14.2 ± 3.1 15.0 ± 4.6 0.003
PACS, % 12.5 ± 3.9 14.1 ± 5.1 12.1 ± 3.4 18.2 ± 3.9*,** 12.6 ± 3.2 13.2 ± 4.8 <0.001
LAVI, ml/m2 27.8 ± 7.4 26.4 ± 5.8 26.6 ± 6.6 25.3 ± 5.0 28.4 ± 8.7 27.9 ± 6.2 0.435

HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEF, left ventricular ejection fraction; GLS, global longitudinal strain; TRV, tricuspid regurgitation velocity; PALS, peak atrial longitudinal strain; PACS, peak atrial contraction strain; LAVI, left atrial volume index.

*

p < 0.05 vs. control.

**

p < 0.05 vs. the intervention arm.